SK69794A3 - Pyridazines as inhibitors of enzyme, converting the interleukin-1-beta - Google Patents
Pyridazines as inhibitors of enzyme, converting the interleukin-1-beta Download PDFInfo
- Publication number
- SK69794A3 SK69794A3 SK697-94A SK69794A SK69794A3 SK 69794 A3 SK69794 A3 SK 69794A3 SK 69794 A SK69794 A SK 69794A SK 69794 A3 SK69794 A3 SK 69794A3
- Authority
- SK
- Slovakia
- Prior art keywords
- chloro
- pyridazine
- group
- carboxamido
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7391493A | 1993-06-08 | 1993-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK69794A3 true SK69794A3 (en) | 1995-02-08 |
Family
ID=22116553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK697-94A SK69794A3 (en) | 1993-06-08 | 1994-06-07 | Pyridazines as inhibitors of enzyme, converting the interleukin-1-beta |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US6121266A (xx) |
| EP (1) | EP0628550B1 (xx) |
| JP (1) | JPH0769894A (xx) |
| KR (1) | KR950000673A (xx) |
| AT (1) | ATE163412T1 (xx) |
| AU (1) | AU693786B2 (xx) |
| CA (1) | CA2125359A1 (xx) |
| CZ (1) | CZ140194A3 (xx) |
| DE (1) | DE69408598T2 (xx) |
| DK (1) | DK0628550T3 (xx) |
| ES (1) | ES2114654T3 (xx) |
| FI (1) | FI942693A (xx) |
| HU (1) | HUT67413A (xx) |
| IL (1) | IL109918A0 (xx) |
| NO (1) | NO306061B1 (xx) |
| NZ (1) | NZ260698A (xx) |
| RU (1) | RU94019984A (xx) |
| SK (1) | SK69794A3 (xx) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US6008217A (en) * | 1995-12-20 | 1999-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| ATE163412T1 (de) | 1993-06-08 | 1998-03-15 | Sanofi Sa | Pyridazine als interleukin-1-beta verwandlungsenzym inhibitoren |
| US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US6420522B1 (en) | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US5847135A (en) * | 1994-06-17 | 1998-12-08 | Vertex Pharmaceuticals, Incorporated | Inhibitors of interleukin-1β converting enzyme |
| CA2215211A1 (en) * | 1995-03-31 | 1996-10-03 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
| US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
| GB9715640D0 (en) * | 1997-07-24 | 1997-10-01 | M J Highway Technology Limited | Road repair material |
| TWI241295B (en) * | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
| JP2000247959A (ja) * | 1999-02-26 | 2000-09-12 | Kowa Co | ピリダジン−３−オン誘導体及びこれを含有する医薬 |
| EP2241328A1 (en) | 2000-05-12 | 2010-10-20 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
| US6664256B1 (en) | 2000-07-10 | 2003-12-16 | Kowa Co., Ltd. | Phenylpyridazine compounds and medicines containing the same |
| EP2264014A1 (en) | 2001-08-31 | 2010-12-22 | Université Louis Pasteur | Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors |
| TWI314455B (en) * | 2002-12-10 | 2009-09-11 | Nippon Kayaku Kk | 3-phenyl-cinnoline derivatives and anti-tumor agent containing the same |
| WO2004083188A1 (ja) | 2003-03-18 | 2004-09-30 | Kowa Co., Ltd. | 水溶性フェニルピリダジン誘導体及びこれを含有する医薬 |
| WO2005058834A2 (en) * | 2003-12-12 | 2005-06-30 | Wyeth | Quinolines useful in treating cardiovascular disease |
| CA2557508C (en) * | 2004-02-26 | 2016-08-16 | Baylor Research Institute | Compositions and methods for the systemic treatment of arthritis |
| ZA200610133B (en) * | 2004-05-15 | 2008-05-28 | Vertex Pharma | Treating seizures using ice inhibitors |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| ES2543813T3 (es) | 2004-11-02 | 2015-08-24 | Northwestern University | Compuestos de piridazina para el tratamiento de enfermedades inflamatorias |
| EP1812007B1 (en) | 2004-11-02 | 2011-09-07 | Northwestern University | Pyridazine compounds and methods |
| US8158627B2 (en) | 2006-04-28 | 2012-04-17 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| CA2650625A1 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| WO2007127475A2 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Pyridazines for demyelinating diseases and neuropathic pain |
| WO2012075393A2 (en) * | 2010-12-02 | 2012-06-07 | President And Fellows Of Harvard College | Activators of proteasomal degradation and uses thereof |
| US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
| KR102419136B1 (ko) | 2017-06-15 | 2022-07-08 | 삼성전자주식회사 | 다채널 특징맵을 이용하는 영상 처리 장치 및 방법 |
| SG11202100137TA (en) * | 2018-07-09 | 2021-02-25 | Lieber Institute Inc | PYRIDAZINE COMPOUNDS FOR INHIBITING Nav1.8 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1603244A (en) * | 1977-05-20 | 1981-11-18 | Max Planck Gesellschaft | Medicaments for the suppression of pathological processes |
| FR2511366A1 (fr) * | 1981-08-11 | 1983-02-18 | Sanofi Sa | Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
| US4590194A (en) * | 1981-10-05 | 1986-05-20 | Sterling Drug Inc. | 3-[methyl or dimethyl)amino]-6-(pyridinyl)pyridazines and their cardiotonic use |
| IE860511L (en) * | 1985-03-01 | 1986-09-01 | Alfa Farmaceutici Spa | "Benzoyl urea derivatives having anti-tumor activity" |
| US5055451A (en) * | 1986-12-22 | 1991-10-08 | Syntex Inc. | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
| DE4134467A1 (de) * | 1991-10-18 | 1993-04-22 | Thomae Gmbh Dr K | Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5081145A (en) * | 1990-02-01 | 1992-01-14 | Merck Frosst Canada, Inc. | Indole-2-alkanoic acids compositions of and anti allergic use thereof |
| AU7775991A (en) * | 1990-04-04 | 1991-10-30 | Immunex Corporation | Interleukin 1beta protease |
| EP0519748B1 (en) * | 1991-06-21 | 1998-09-02 | Merck & Co. Inc. | Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme |
| ATE163412T1 (de) | 1993-06-08 | 1998-03-15 | Sanofi Sa | Pyridazine als interleukin-1-beta verwandlungsenzym inhibitoren |
-
1994
- 1994-06-04 AT AT94201597T patent/ATE163412T1/de not_active IP Right Cessation
- 1994-06-04 DK DK94201597T patent/DK0628550T3/da active
- 1994-06-04 ES ES94201597T patent/ES2114654T3/es not_active Expired - Lifetime
- 1994-06-04 DE DE69408598T patent/DE69408598T2/de not_active Expired - Lifetime
- 1994-06-04 EP EP94201597A patent/EP0628550B1/en not_active Expired - Lifetime
- 1994-06-07 IL IL10991894A patent/IL109918A0/xx unknown
- 1994-06-07 CA CA002125359A patent/CA2125359A1/en not_active Abandoned
- 1994-06-07 SK SK697-94A patent/SK69794A3/sk unknown
- 1994-06-07 NZ NZ260698A patent/NZ260698A/en unknown
- 1994-06-07 JP JP6125091A patent/JPH0769894A/ja active Pending
- 1994-06-07 RU RU94019984/04A patent/RU94019984A/ru unknown
- 1994-06-07 AU AU64556/94A patent/AU693786B2/en not_active Ceased
- 1994-06-07 KR KR1019940012681A patent/KR950000673A/ko not_active Application Discontinuation
- 1994-06-08 HU HU9401714A patent/HUT67413A/hu unknown
- 1994-06-08 FI FI942693A patent/FI942693A/fi unknown
- 1994-06-08 NO NO942133A patent/NO306061B1/no not_active IP Right Cessation
- 1994-06-08 CZ CZ941401A patent/CZ140194A3/cs unknown
-
1995
- 1995-05-19 US US08/444,984 patent/US6121266A/en not_active Expired - Lifetime
-
1996
- 1996-04-03 US US08/625,680 patent/US6624166B1/en not_active Expired - Fee Related
-
2003
- 2003-09-22 US US10/668,475 patent/US6995261B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0628550A2 (en) | 1994-12-14 |
| HU9401714D0 (en) | 1994-09-28 |
| JPH0769894A (ja) | 1995-03-14 |
| DE69408598T2 (de) | 1998-09-17 |
| ATE163412T1 (de) | 1998-03-15 |
| EP0628550A3 (en) | 1995-01-18 |
| DE69408598D1 (de) | 1998-04-02 |
| IL109918A0 (en) | 1994-10-07 |
| RU94019984A (ru) | 1997-04-10 |
| ES2114654T3 (es) | 1998-06-01 |
| US6624166B1 (en) | 2003-09-23 |
| US6995261B2 (en) | 2006-02-07 |
| CZ140194A3 (en) | 1995-01-18 |
| NO942133L (no) | 1994-12-09 |
| FI942693A (fi) | 1994-12-09 |
| EP0628550B1 (en) | 1998-02-25 |
| US20040110725A1 (en) | 2004-06-10 |
| AU693786B2 (en) | 1998-07-09 |
| NZ260698A (en) | 1996-09-25 |
| AU6455694A (en) | 1994-12-15 |
| FI942693A0 (fi) | 1994-06-08 |
| NO306061B1 (no) | 1999-09-13 |
| DK0628550T3 (da) | 1998-09-28 |
| US6121266A (en) | 2000-09-19 |
| CA2125359A1 (en) | 1994-12-09 |
| NO942133D0 (no) | 1994-06-08 |
| KR950000673A (ko) | 1995-01-03 |
| HUT67413A (en) | 1995-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK69794A3 (en) | Pyridazines as inhibitors of enzyme, converting the interleukin-1-beta | |
| EP0623606B1 (en) | Peptidic ketones as interleukin-1beta-converting enzyme inhibitors | |
| KR100814599B1 (ko) | 신경퇴행성 장애 치료용 이미다졸 화합물 | |
| US5250548A (en) | Angiotensin II receptor antagonists | |
| SU1584750A3 (ru) | Способ получени производных 3(2Н)-пиридазинона | |
| AU2018371010B2 (en) | Sulfone pyridine alkyl amide-substituted heteroaryl compounds | |
| AU8539198A (en) | Barbituric acid derivatives with antimetastatic and antitumor activity | |
| CZ137994A3 (en) | Peptide phosphonyloxymethyl ketone, pharmaceutical composition containing thereof and the use of such ketone or the pharmaceutical composition | |
| KR20000064716A (ko) | 약학적으로유용한화합물 | |
| JPH10182583A (ja) | 新規ヒドロキサム酸誘導体 | |
| CN110461836B (zh) | 一种选择性抑制激酶化合物及其用途 | |
| ES2362877T3 (es) | Compuestos de imidazolin-2-ona. | |
| KR20220034853A (ko) | 인터류킨의 조정에서의 전구약물 | |
| HUT71559A (en) | 4-oxo-3h,5h-pyrrolo[3,2-d]pyrimidine and pharmaceutical compositions containing them | |
| US20050020533A1 (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
| JP7266090B2 (ja) | 新規なｎ－（イソプロピル－トリアゾリル）ピリジニル）－ヘテロアリール－カルボキサミド誘導体及びその用途 | |
| JP4101905B2 (ja) | ４−アミノ−２−ウレイドピリミジン−５−カルボキサミド、それらの製法、これらの化合物を含有する医薬およびそれらの使用 | |
| KR20020010669A (ko) | 시스-[4-시아노-4-(3-시클로펜틸옥시-4-메톡시페닐)시클로헥산-1-카르복실레이트의 염 | |
| JPH0136820B2 (xx) |